VSEL (Very Small Embryonic-Like) Therapy utilizes adult pluripotent stem cells, approximately one-third the size of typical stem cells, for advanced regenerative treatment. These cells, capable of crossing the blood-brain barrier, are activated from a patient’s blood through specialized processes involving light and temperature. VSEL therapy targets areas of injury, inflammation, and degeneration, promoting tissue repair and regeneration. This therapy has shown effectiveness in treating autoimmune diseases, osteoporosis, and musculoskeletal conditions, enhancing overall health by triggering telomerase secretion to restore DNA telomere ends.
Features
- Pluripotent Stem Cells
- Non-Tumorigenic
- Telomerase Activation
- Crosses Blood-Brain Barrier
- Regenerative Therapy
Benefits
- Enhanced Healing
- Reduced Inflammation
- Anti-Aging Effects
- Improved Bone Density
- Safe and Natural
Process
Scientific Backing
Studies highlight VSEL’s ability to enhance cell regeneration, reduce inflammation, and stimulate telomerase, which combats aging. Clinical trials have shown significant improvements in bone density and musculoskeletal health. Research indicates these cells’ potential in treating autoimmune diseases and other chronic conditions, providing a safe, non-tumorigenic alternative to traditional therapies.